Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Quazepam

A long-acting benzodiazepine, patented in 1970 and in clinical use since 1985 for the treatment of insomnia: it binds selectively to GABA-A receptors containing the alpha-1 subunit, linked mainly to sleep induction. This family brings together other impurities.

Did you know?Its structure has a sulphur atom where benzodiazepines such as diazepam have an oxygen: in the body the sulphur is replaced by oxygen, forming the active metabolite 2-oxoquazepam.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.